Hi! 👋 We have a new venture. Please check out Satire Labs 😉.
The funniest way to turn your $100 to $1 million. ⛴️ 🚢.
Note: This is a joke. Kinda. We really do think you'll make money 😎🙂

  Petmed Express Inc ( PETS ) |
2000 - 2021 (22 years)

Net Revenue (Sales) is 
$293.7M (1Y -0.09% )

PETS Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for PETS competitors.
CJJD CVS RAD WBA
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $65.9M +5.5x
( +8.9% / year avg)
chevron_left 2000 $10.2M
vertical_align_top Peak $305.8M +29.0x
vertical_align_bottom Bottom $10.2M
arrow_drop_up # Up Years 16 16 of 22
years up.
arrow_drop_down # Down Years 6
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • PETS's stock price has rallied +436% from $5.44 in 2000 , or +0.61x the rate relative to it's net revenue (sales) over the same period.
  • If PETS grows it's stock at the same rate as it's net revenue (sales) (+8.9%/year) , it's stock price will grow +234% and hit $68.43 over the next 10 years.
  • PETS's stock price has gone up 12 of the 16 years (+75%) it's net revenue (sales) were also up.
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001
    1 Revenue 284125000 283419000 273800000 249176000 234684000 229395000 233391000 227829000 238250000 231642000 238266000 219412247 188336469 162246407 137583155 108357747 93994233 54974916 32025931 10006285
    2 Cost of Revenue 202879000.00 188105000.00 175993000.00 169862000.00 158388000.00 153125000.00 155774000.00 150708000.00 158085000.00 147686000.00 146405000.00 134084680.00 114122433.00 97680238.00 83244366.00 64700002.00 55824406.00 31517639.00 18894493.00 6367604.00
    3 Gross Profit (Income) 81246000.00 95314000.00 97807000.00 79314000.00 76296000.00 76270000.00 77617000.00 77121000.00 80165000.00 83956000.00 91861000.00 85327567.00 74214036.00 64566169.00 54338789.00 43657745.00 38169827.00 23457277.00 13131438.00 3638681.00
    4 R&D 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 SG&A 25264000.00 24767000.00 24290000.00 22799000.00 21301000.00 21101000.00 21352000.00 21592000.00 22363000.00 22200000.00 22341000.00 21604654.00 20367392.00 17292675.00 14078343.00 11396320.00 10754427.00 7956786.00 6094493.00 4506509.00
    6 Other Expenses 1169000.00 1083000.00 995000.00 300000.00 63000.00 1000.00 -4000.00 -5000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Operating Expenses 50269000.00 49140000.00 45671000.00 41831000.00 43908000.00 46943000.00 49399000.00 50116000.00 54143000.00 50932000.00 51319000.00 51126582.00 46218424.00 43066144.00 36193545.00 31156119.00 28958433.00 19974270.00 12383498.00 6277779.00
    8 Interest Expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 D&A 2257000.00 2225000.00 2126000.00 1369000.00 770000.00 660000.00 867000.00 1091000.00 1411000.00 1375000.00 1321000.00 814542.00 589990.00 530440.00 544535.00 573817.00 550392.00 367673.00 376763.00 373852.00
    10 EBITDA 33234000.00 48399000.00 54262000.00 38852000.00 33158000.00 29987000.00 29085000.00 28096000.00 27433000.00 34399000.00 41863000.00 35015527.00 28585602.00 22030465.00 18689779.00 13075443.00 9761786.00 3850680.00 1124703.00 -2265246.00
    11 Operating Income 30977000.00 46174000.00 52136000.00 37483000.00 32388000.00 29327000.00 28218000.00 27005000.00 26022000.00 33024000.00 40542000.00 34200985.00 27995612.00 21500025.00 18145244.00 12501626.00 9211394.00 3483007.00 747940.00 -2639098.00
    12 Other Income Expenses (Net) 1169000.00 1083000.00 995000.00 300000.00 -11000.00 -1713000.00 -4000.00 -5000.00 61000.00 -128000.00 4000.00 399584.00 643880.00 434574.00 213867.00 3710.00 6938.00 21084.00 -87274.00 -9117.00
    13 Pre-Income Tax 33893000.00 49121000.00 53789000.00 37924000.00 32567000.00 27798000.00 28399000.00 27306000.00 26371000.00 33277000.00 40742000.00 35656646.00 30411145.00 23200749.00 19035194.00 12603415.00 9213525.00 3480406.00 825413.00 -2826707.00
    14 Income Tax Expense 8042000.00 11381000.00 16506000.00 14105000.00 12000000.00 10345000.00 10427000.00 10141000.00 9712000.00 12406000.00 14740000.00 12680235.00 10388914.00 8757247.00 6971680.00 4593045.00 3399921.00 222841.00 0.00 0.00
    15 Net Income 25851000.00 37740000.00 37283000.00 23819000.00 20567000.00 17453000.00 17972000.00 17165000.00 16659000.00 20871000.00 26002000.00 22976411.00 20022231.00 14443502.00 12063514.00 8010370.00 5813604.00 3257565.00 825413.00 -2826707.00
    16 EPS 1.29 1.84 1.83 1.18 1.02 0.87 0.90 0.86 0.81 0.93 1.15 0.99 0.83 0.60 0.51 0.35 0.30 0.19 0.05 -0.28
    17 EPS Diluted 1.29 1.84 1.82 1.17 1.02 0.87 0.90 0.86 0.80 0.92 1.14 0.98 0.82 0.60 0.50 0.34 0.25 0.16 0.04 -0.28
    18 Shares Outstanding 20041000.00 20461000.00 20346000.00 20232000.00 20124000.00 20015000.00 19901000.00 19926000.00 20613000.00 22514000.00 22616785.00 23305726.00 24088258.00 24109035.00 23658722.00 22862417.00 19471681.00 17300130.00 16360010.00 9943625.00
    19 Shares Outstanding (Diluted) 20055000.00 20491000.00 20433000.00 20378000.00 20254000.00 20136000.00 20043000.00 20049000.00 20708000.00 22643000.00 22746433.00 23482177.00 24299364.00 24270879.00 24211955.00 23833189.00 23689866.00 20749515.00 19739493.00 9943625.00
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001
    1 Cash & Cash Equivalents 103762000.00 100529000.00 77936000.00 58730000.00 37639000.00 35613000.00 18305000.00 18155000.00 46801000.00 49660000.00 53143000.00 30126041.00 20267829.00 316470.00 23216907.00 12680962.00 3278926.00 984169.00 737284.00 408699.00
    2 Short Term Investments 0.00 0.00 0.00 0.00 0.00 15591000.00 15539000.00 15490000.00 10347000.00 10116000.00 0.00 0.00 4780000.00 39125000.00 0.00 0.00 0.00 0.00 0.00 0.00
    3 Cash & S-T Investments 103762000.00 100529000.00 77936000.00 58730000.00 37639000.00 51204000.00 33844000.00 33645000.00 57148000.00 59776000.00 53143000.00 30126041.00 25047829.00 39441470.00 23216907.00 12680962.00 3278926.00 984169.00 737284.00 408699.00
    4 Accounts Receivables 3843000.00 2542000.00 2292000.00 1808000.00 1724000.00 1931000.00 1761000.00 1439000.00 1572000.00 1985000.00 2097000.00 2881085.00 1575263.00 1369521.00 1155781.00 1796756.00 1133301.00 651883.00 291513.00 162468.00
    5 Inventory 17884000.00 21370000.00 23337000.00 20228000.00 25586000.00 25068000.00 35727000.00 31601000.00 26217000.00 25140000.00 29064000.00 26778096.00 17909549.00 16086207.00 14997675.00 11180333.00 11179858.00 4268146.00 2306620.00 631394.00
    6 Other Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 724561.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Total Current Assets 129018000.00 126431000.00 105235000.00 81785000.00 67627000.00 80400000.00 74209000.00 70187000.00 87607000.00 89604000.00 86499000.00 61625128.00 45224500.00 57968369.00 39953401.00 25871203.00 15824303.00 6382306.00 3484025.00 1224675.00
    8 PP&E 25445000.00 27136000.00 28741000.00 30164000.00 20929000.00 1569000.00 1310000.00 2132000.00 2597000.00 3433000.00 4429000.00 5057561.00 1903294.00 1990578.00 1497589.00 1286267.00 1688327.00 1496979.00 1120056.00 3185851.00
    9 Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    10 Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 860000.00 850000.00 850000.00 365000.00 365000.00 365000.00 365000.00 365000.00 365000.00 0.00 0.00
    11 Goodwill & Intangible Assets 860000.00 860000.00 860000.00 860000.00 860000.00 860000.00 860000.00 860000.00 860000.00 860000.00 850000.00 850000.00 365000.00 365000.00 365000.00 365000.00 365000.00 365000.00 0.00 0.00
    12 L-T Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12000000.00 12000000.00 14000000.00 25000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    13 Tax Assets 0.00 0.00 0.00 0.00 863000.00 23000.00 0.00 0.00 0.00 0.00 0.00 0.00 1221853.00 894540.00 794002.00 582846.00 581356.00 581356.00 0.00 0.00
    14 Other Non-Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 24740000.00 0.00 14167.00 14167.00 21822.00 200155.00 50155.00 94231.00
    15 Total Non-Current Assets 26305000.00 27996000.00 29601000.00 31024000.00 22652000.00 2452000.00 4166000.00 2992000.00 3457000.00 16683000.00 17671000.00 20337811.00 28230147.00 3250118.00 2670758.00 2248280.00 2656505.00 2643490.00 1170211.00 3280082.00
    16 Other Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 155323000.00 154427000.00 134836000.00 112809000.00 90279000.00 82852000.00 78375000.00 73179000.00 91064000.00 106287000.00 104170000.00 81962939.00 73454647.00 61218487.00 42624159.00 28119483.00 18480808.00 9025796.00 4654236.00 4504757.00
    18 Accounts Payables 19658000.00 16275000.00 15274000.00 15221000.00 5004000.00 5153000.00 5768000.00 6454000.00 6619000.00 6452000.00 4776000.00 4817097.00 4358774.00 5859756.00 3052953.00 2724990.00 3273062.00 3296223.00 2724995.00 1542166.00
    19 S-T Debt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 68442.00 68442.00 68442.00 1905810.00
    20 Income Tax Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Current Liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 185243.00 229321.00 958318.00 601535.00 422445.00 0.00 0.00 250048.00
    23 Total Current Liabilities 24343000.00 18626000.00 18109000.00 18355000.00 7084000.00 7417000.00 8093000.00 8997000.00 9391000.00 8961000.00 7088000.00 6994935.00 6420672.00 7354914.00 4984630.00 3902419.00 4486299.00 3364665.00 2793437.00 3698024.00
    24 L-T Debt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 68443.00 278099.00 0.00
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001
    1 Net Income (Earnings) 25851000.00 37740000.00 37283000.00 23819000.00 20567000.00 17453000.00 17972000.00 17165000.00 16659000.00 20871000.00 26002000.00 22976411.00 20022231.00 14443502.00 12063514.00 8010370.00 5813604.00 3257565.00 825413.00 -2826707.00
    2 D&A 2257000.00 2225000.00 2126000.00 1369000.00 770000.00 660000.00 867000.00 1091000.00 1411000.00 1375000.00 1321000.00 814542.00 589990.00 530440.00 544535.00 573817.00 550392.00 367673.00 236715.00 -88287.00
    3 Deferred Income Tax -151000.00 125000.00 -92000.00 1951000.00 -23000.00 157000.00 -183000.00 -76000.00 -56000.00 348000.00 -305000.00 497292.00 -327313.00 -100538.00 -211156.00 -1490.00 0.00 -581356.00 0.00 0.00
    4 Stock-Based Compensation (SBC) 2822000.00 3097000.00 2575000.00 1935000.00 1612000.00 1481000.00 1479000.00 1943000.00 2246000.00 2171000.00 1594000.00 1464225.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 Change in Working Capital -3130000.00 20679000.00 23696000.00 2887000.00 -12440000.00 6867000.00 4926000.00 -17026000.00 -2427000.00 1232000.00 24780807.00 15826365.00 -11809627.00 15644684.00 12999987.00 10630780.00 8320363.00 2327053.00 3163937.00 -2871567.00
    6 Accounts Receivables -1492000.00 -335000.00 -596000.00 -505000.00 -53000.00 -264000.00 -417000.00 77000.00 366000.00 64000.00 766000.00 -1379803.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Inventory 3486000.00 1967000.00 -3109000.00 5358000.00 -518000.00 10659000.00 -4126000.00 -5384000.00 -1077000.00 3924000.00 -2286000.00 -8868547.00 -1823342.00 -1088532.00 -3817342.00 -475.00 -6911712.00 -1961526.00 -1675226.00 1121302.00
    8 Accounts Payables 3383000.00 1001000.00 53000.00 10217000.00 -149000.00 -616000.00 -686000.00 -165000.00 297000.00 1964000.00 313000.00 -313436.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 Other Working Capital 104675000.00 107805000.00 87126000.00 63430000.00 60543000.00 72983000.00 66116000.00 61190000.00 78216000.00 80643000.00 79411000.00 54630193.00 38803828.00 50613455.00 34968771.00 21968784.00 11338004.00 3017641.00 690588.00 -2473349.00
    10 Other Non-Cash Items 0.00 0.00 0.00 0.00 0.00 1714000.00 0.00 0.00 16706000.00 48000.00 18000.00 73981.00 1720423.00 1125294.00 0.00 0.00 0.00 0.00 0.00 0.00
    11 Net Cash Provided by Operating Activities 38844000.00 45138000.00 37379000.00 47204000.00 21053000.00 32043000.00 13506000.00 13290000.00 20391000.00 30106000.00 27685000.00 14965684.00 19380494.00 16564440.00 10277490.00 8348799.00 1105595.00 970301.00 476024.00 -1046583.00
    12 Investments in PP&E -2311000.00 -620000.00 -703000.00 -10604000.00 -20130000.00 -918000.00 -45000.00 -626000.00 -705000.00 -677000.00 -1047000.00 -3692615.00 -502706.00 -1025079.00 -758176.00 -171757.00 -741740.00 -744596.00 -555645.00 -241888.00
    13 Acquisitions (Net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Purchase of Investments 0.00 0.00 0.00 0.00 0.00 -68000.00 -84000.00 -5189000.00 0.00 0.00 0.00 0.00 0.00 -16275000.00 0.00 0.00 0.00 0.00 0.00 0.00
    15 Sales/Maturities of Investments 0.00 0.00 0.00 0.00 15645000.00 0.00 0.00 0.00 0.00 0.00 2150000.00 14870000.00 9605000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    16 Other Investing Activities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -365000.00 0.00 311429.00
    17 Net Cash used for Investing Activities -2311000.00 -620000.00 -703000.00 -10604000.00 -4485000.00 -986000.00 -129000.00 -5815000.00 11639000.00 -10823000.00 1103000.00 11179385.00 9102294.00 -17299679.00 -757576.00 -171757.00 -741740.00 -1094596.00 1461276.00 69541.00
    18 Debt Repayment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    19 Common Stock Issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2784987.00 442084.00 1016031.00 1293436.00 1999345.00 580836.00 0.00 1954142.00
    20 Common Stock Repurchased -11497000.00 0.00 0.00 0.00 0.00 0.00 0.00 -3865000.00 -23685000.00 -12247000.00 0.00 -18447539.00 -11600721.00 0.00 0.00 0.00 0.00 0.00 0.00 -1000.00
    21 Dividends Paid -21803000.00 -21925000.00 -17470000.00 -15509000.00 -14684000.00 -13807000.00 -13326000.00 -31972000.00 -10964000.00 -10727000.00 -6805000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Financing Activities 0.00 0.00 0.00 0.00 142000.00 58000.00 99000.00 -284000.00 -240000.00 -132000.00 299000.00 267835.00 284305.00 242718.00 0.00 0.00 0.00 0.00 0.00 0.00
    23 Net Cash Used Provided by Financing Activities -33300000.00 -21925000.00 -17470000.00 -15509000.00 -14542000.00 -13749000.00 -13227000.00 -36121000.00 -34889000.00 -22766000.00 -5771000.00 -16286857.00 -8531429.00 684802.00 1016031.00 1224994.00 1930902.00 371180.00 -1608715.00 1073895.00
    24 Net Change in Cash 3233000.00 22593000.00 19206000.00 21091000.00 2026000.00 17308000.00 150000.00 -28646000.00 -2859000.00 -3483000.00 23017000.00 9858212.00 19951359.00 -50437.00 10535945.00 9402036.00 2294757.00 246885.00 328585.00 96853.00
  • About
    Industry: Pharmaceutical Retailers
    Sector: Healthcare
    Country: US
    IPO Date: 4/6/2000
    Stonk Exchange: NASDAQ
    • PetMed Express, Inc
    • engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats.
    • The company is headquartered in Delray Beach, Florida and currently employs 199 full-time employees.
    • The firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer.
    • The company offers a selection of products for dogs and cats.
    • Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
    • Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl.
    • The company also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties.
    • These pet supplies include food, beds, crates, stairs, strollers and other pet supplies.
    • Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx).
    • Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.